Autor: |
Obradovic J; Department of Sciences, Institute for Information Technologies Kragujevac, University of Kragujevac, Kragujevac, Serbia., Todosijevic J; Faculty of Science, Institute of Biology and Ecology, University of Kragujevac, Kragujevac, Serbia., Jurisic V; Faculty of Medical Sciences, University of Kragujevac, 34000, Kragujevac, Serbia. jurisicvladimir@gmail.com. |
Jazyk: |
angličtina |
Zdroj: |
Molecular biology reports [Mol Biol Rep] 2021 Apr; Vol. 48 (4), pp. 3593-3604. Date of Electronic Publication: 2021 May 10. |
DOI: |
10.1007/s11033-021-06379-w |
Abstrakt: |
Variants in the epidermal growth factor receptor (EGFR) gene are recognized as predictors of therapy response and are correlated with progression-free and overall survival in non-small cell lung cancer (NSCLC) patients. Molecularly guided therapy needs precise and cost-effective molecular tests. This review focused primarily on screening or target methods for the EGFR variants detection with diagnostic and prognostic potential in the clinical research published papers. Concerning the inclusion and exclusion criteria, the search interval comprised available articles published from 2010 until 2020 in three electronic databases, ISI Web of Science, Pub Med, and Scopus. The analysis of eligible studies started with 5647 and obtained the final 987 full-text articles analyzed as clinical research. The regions comprised were Africa, America, Australia, Asia, Euro-Asia, Europe, or a consortium of different countries. All of the tested methods were applied prevalently in Asia. In clinical research, the polymerase chain reaction (PCR), followed by sequencing methods have been involved mostly over the years. The identified high-through output approaches evolved to improve the survival and quality of the NSCLC patient's life becoming more sensitive, specific, and cost-effective. |
Databáze: |
MEDLINE |
Externí odkaz: |
|